These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 14600076

  • 1. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells.
    Weber SM, Scarim AL, Corbett JA.
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E329-36. PubMed ID: 14600076
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2.
    Weber SM, Scarim AL, Corbett JA.
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E883-91. PubMed ID: 12517740
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [Abstract] [Full Text] [Related]

  • 4. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling.
    Weber SM, Chambers KT, Bensch KG, Scarim AL, Corbett JA.
    Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1171-7. PubMed ID: 15315910
    [Abstract] [Full Text] [Related]

  • 5. PGJ2-stimulated beta-cell apoptosis is associated with prolonged UPR activation.
    Chambers KT, Weber SM, Corbett JA.
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1052-61. PubMed ID: 17148750
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon DY, Hong JT.
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H, Di Battista JA, Pelletier JP, Mineau F, Ranger P, Martel-Pelletier J.
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [Abstract] [Full Text] [Related]

  • 8. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.
    Maggi LB, Sadeghi H, Weigand C, Scarim AL, Heitmeier MR, Corbett JA.
    Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955
    [Abstract] [Full Text] [Related]

  • 9. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
    Guyton K, Zingarelli B, Ashton S, Teti G, Tempel G, Reilly C, Gilkeson G, Halushka P, Cook J.
    Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
    [Abstract] [Full Text] [Related]

  • 12. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S, Rattan R, Singh AK, Singh I.
    J Immunol; 2004 Oct 15; 173(8):5196-208. PubMed ID: 15470065
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW, Chang YH, Tsi CJ, Lin WW.
    J Immunol; 2003 Jul 15; 171(2):979-88. PubMed ID: 12847270
    [Abstract] [Full Text] [Related]

  • 14. Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts.
    Khan E, Abu-Amer Y.
    J Lab Clin Med; 2003 Jul 15; 142(1):29-34. PubMed ID: 12878983
    [Abstract] [Full Text] [Related]

  • 15. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG.
    Br J Pharmacol; 2004 Feb 15; 141(3):517-25. PubMed ID: 14718259
    [Abstract] [Full Text] [Related]

  • 16. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.
    Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD.
    J Leukoc Biol; 2002 Apr 15; 71(4):677-85. PubMed ID: 11927655
    [Abstract] [Full Text] [Related]

  • 17. 15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression.
    Zhao ML, Brosnan CF, Lee SC.
    J Neuroimmunol; 2004 Aug 15; 153(1-2):132-42. PubMed ID: 15265671
    [Abstract] [Full Text] [Related]

  • 18. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.
    Mol Pharmacol; 2005 Jul 15; 68(1):169-78. PubMed ID: 15821150
    [Abstract] [Full Text] [Related]

  • 19. 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells.
    Ichiki T, Tokunou T, Fukuyama K, Iino N, Masuda S, Takeshita A.
    Biochem Biophys Res Commun; 2004 Oct 15; 323(2):402-8. PubMed ID: 15369766
    [Abstract] [Full Text] [Related]

  • 20. 15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).
    Chiba T, Ueki S, Ito W, Kato H, Takeda M, Kayaba H, Furue M, Chihara J.
    Int Arch Allergy Immunol; 2009 Oct 15; 149 Suppl 1():77-82. PubMed ID: 19494510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.